Topical steroid addiction in atopic dermatitis

Review, Article English OPEN
Fukaya, Mototsugu ; Sato,Kenji ; Sato,Mitsuko ; Kimata,Hajime ; Fujisawa,Shigeki ; Yoshizawa,Jun ; Dozono,Haruhiko ; Minaguchi,Satoko (2014)
  • Publisher: Dove Press
  • Journal: Drug, Healthcare and Patient Safety, volume 6, pages 131-138 (issn: 1179-1365, eissn: 1179-1365)
  • Related identifiers: pmc: PMC4207549, doi: 10.2147/DHPS.S6920, doi: 10.2147/DHPS.S69201
  • Subject: rebound | R5-920 | Review | red burning skin syndrome | Medicine (General) | corticosteroid | eczema | atopic dermatitis | topical steroid addiction | Drug, Healthcare and Patient Safety

Mototsugu Fukaya,1 Kenji Sato,2 Mitsuko Sato,3 Hajime Kimata,4 Shigeki Fujisawa,5 Haruhiko Dozono,6 Jun Yoshizawa,7 Satoko Minaguchi8 1Tsurumai Kouen Clinic, Nagoya, 2Department of Dermatology, Hannan Chuo Hospital, Osaka, 3Sato Pediatric Clinic, Osaka, 4Kimata Hajime Clinic, Osaka, 5Fujisawa Dermatology Clinic, Tokyo, 6Dozono Medical House, Kagoshima, 7Yoshizawa Dermatology Clinic, Yokohama, 8Department of Dermatology, Kounosu Kyousei Hospital, Saitama, Japan Abstract: The American Academy of Dermatology published a new guideline regarding topical therapy in atopic dermatitis in May 2014. Although topical steroid addiction or red burning skin syndrome had been mentioned as possible side effects of topical steroids in a 2006 review article in the Journal of the American Academy of Dermatology, no statement was made regarding this illness in the new guidelines. This suggests that there are still controversies regarding this illness. Here, we describe the clinical features of topical steroid addiction or red burning skin syndrome, based on the treatment of many cases of the illness. Because there have been few articles in the medical literature regarding this illness, the description in this article will be of some benefit to better understand the illness and to spur discussion regarding topical steroid addiction or red burning skin syndrome. Keywords: topical steroid addiction, atopic dermatitis, red burning skin syndrome, rebound, corticosteroid, eczema
  • References (17)
    17 references, page 1 of 2

    1. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1-15.

    2. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116-132.

    3. [homepage on the Internet]. NEA forms Scientific Advisory Committee Task Force to study topical steroid addiction. National Eczema Association; 2014. Available from: http:// Accessed August 20, 2014.

    4. Burry JN. Topical drug addiction: adverse effects of fluorinated corti - costeroid creams and ointments. Med J Aust. 1973;1(8):393-396.

    5. Kligman AM, Frosch PJ. Steroid addiction. Int J Dermatol. 1979;18(1): 23-31.

    6. Rapaport MJ, Lebwohl M. Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome. Clin Dermatol. 2003;21(3): 201-214.

    7. Enomoto T, Arase S, Shigemi F, Takeda K. [Steroid withdrawal syndrome by topical corticosteroid]. Journal of Japanese Cosmetic Science Society. 1991;15:117-124. Japanese.

    8. Narang T, Kumaran MS, Dogra S, Saikia UN, Kumar B. Red scrotum syndrome: idiopathic neurovascular phenomenon or steroid addiction? Sex Health. 2013;10(5):452-455.

    9. Zheng PS, Lavker RM, Lehmann P, Kligman AM. Morphologic investigations on the rebound phenomenon after corticosteroid-induced atrophy in human skin. J Invest Dermatol. 1984;82(4):345-352.

    10. [homepage on the Internet]. Label all topical steroid cremes for potential severe addiction after two weeks use [petition published by Joey Brown]. GoPetition; 2011. Available from: http:// Accessed August 20, 2014.

  • Similar Research Results (2)
  • Metrics
    No metrics available
Share - Bookmark